Answers are grounded in this paper and cite their sources.
Assessment evaluates therapy response in head and neck cancer, indicating challenges with positive predictive value.
PET/CT HCS for therapy response assessment in head and neck cancer serves as a robust Score independent of newer sensitive reconstructions. Despite the high NPV of PET/CT in this situation the unsatisfactory PPV remains challenging.
No takes yet. Share an insight, caveat, or question.
Leike et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: